Fate Therapeutics, a La Jolla, CA-based biotech startup tapping advances in stem cell biology to develop new drugs, says it has gained exclusive rights to technology involving blood-forming stem cells from Children’s Hospital Boston and Massachusetts General Hospital. The hospitals jointly own the technology. Leonard Zon, director of the stem cell program at Children’s and a scientific founder of Fate, developed the stem cell technology. Randall Moon, a stem cell expert at the University of Washington, is another of several scientific founders of Fate.
Read related posts at Xconomy.